Member Info for Robbo666

Your never going to get those 2 minutes reading that back.

Any one who is properly invested here Trans knows the posts to read stop worrying about it.

Well said coco.

For someone so doubtful you spend half your life here posting trans.Find something you believe in your like

a broken record.

What are you talking about .No partnership has been announced yet so the value and future macap is not known.

Dont worry i picked up your 10 shares.

30 odd trades says everything.Sack every sales director ,Area director ,Pricing manager ,product champion .All those

muppets going to meeting after meeting producing nothing but methane.Lean and mean.

Soup i notice Dan specifically referenced large Pharma in the rns.I know you was not of the idea this was on the table any thoughts now?

Its only banter spudulike.

RIsk of probably no more than5% dilution at discounted rate against news of a deal before is a no brainer hold.

Dan has been dangling the partners carrot for months ,after the odd is sorted

he is on the clock to deliver quickly.

Exactly as also asked by the ema and led to subsequent appproval.

1-0 to you nft but its literally just a few days .Karma works both ways

please stay tuned.The money being burnt on your little share is staggering

keep dreaming.

Anything with such a large discount is basically free money so will

be very well entertained.

You might actually learn something turtle orherwise why bother posting.

Sorry turtle Trombone is correct they ĺ are just institutions that hold

shares for you and me.My shares in hargeeaves make up the % .

Tranilast lack of prior fda approval is irrelevant to odd.

Many odds are granted to reformulated or repurposed drugs.

You will be offered 2 for every 35 you own assuming you are invested.They

will send you the offer.

The take up rate will be over 90% at this discount so no more

than 15 mil left i reckon.Those will be picked up by holders

who have subsribed to more .

Your allocation is safe up to the deadline.Not sure how they will fairly

allocate to anyone who has subsribed to more though.

More likely to be picked up by investors asking for more in the offer.